VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-14.02%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$270M
AUM Growth
+$46.4M
Cap. Flow
+$80.5M
Cap. Flow %
29.85%
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
202
Reduced
102
Closed
67

Top Buys

1
O icon
Realty Income
O
$925K
2
LLY icon
Eli Lilly
LLY
$843K
3
MRNA icon
Moderna
MRNA
$824K
4
PFE icon
Pfizer
PFE
$803K
5
MRK icon
Merck
MRK
$796K

Top Sells

1
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$1.76M
2
AEM icon
Agnico Eagle Mines
AEM
$1.5M
3
MOS icon
The Mosaic Company
MOS
$716K
4
STR
Sitio Royalties
STR
$468K
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$424K

Sector Composition

1 Real Estate 18.55%
2 Healthcare 17.07%
3 Materials 11.98%
4 Financials 11.43%
5 Energy 8.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EDIT icon
376
Editas Medicine
EDIT
$248M
$123K 0.05%
10,370
+4,945
+91% +$58.7K
PRTA icon
377
Prothena Corp
PRTA
$460M
$123K 0.05%
4,523
+837
+23% +$22.8K
AKRO icon
378
Akero Therapeutics
AKRO
$3.58B
$122K 0.05%
12,882
+5,080
+65% +$48.1K
CDXS icon
379
Codexis
CDXS
$218M
$122K 0.05%
11,691
+6,668
+133% +$69.6K
FGEN icon
380
FibroGen
FGEN
$48.9M
$122K 0.05%
463
+1
+0.2% +$263
ARVN icon
381
Arvinas
ARVN
$575M
$121K 0.04%
2,880
+532
+23% +$22.4K
TVRD
382
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
$121K 0.04%
369
+10
+3% +$3.28K
RVMD icon
383
Revolution Medicines
RVMD
$7.57B
$120K 0.04%
6,169
-206
-3% -$4.01K
CMPS
384
Compass Pathways
CMPS
$493M
$119K 0.04%
10,986
+4,462
+68% +$48.3K
ERAS icon
385
Erasca
ERAS
$457M
$119K 0.04%
21,337
+9,805
+85% +$54.7K
ITOS
386
DELISTED
iTeos Therapeutics
ITOS
$119K 0.04%
5,790
+1,629
+39% +$33.5K
SAVA icon
387
Cassava Sciences
SAVA
$104M
$119K 0.04%
4,241
+942
+29% +$26.4K
VIR icon
388
Vir Biotechnology
VIR
$732M
$119K 0.04%
4,659
+1,285
+38% +$32.8K
IMVT icon
389
Immunovant
IMVT
$2.99B
$118K 0.04%
30,146
+8,984
+42% +$35.2K
ATAI icon
390
ATAI Life Sciences
ATAI
$980M
$117K 0.04%
32,106
+16,637
+108% +$60.6K
DAWN icon
391
Day One Biopharmaceuticals
DAWN
$773M
$117K 0.04%
6,551
-2,335
-26% -$41.7K
MRUS icon
392
Merus
MRUS
$5.1B
$117K 0.04%
5,183
-330
-6% -$7.45K
RXDX
393
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$117K 0.04%
4,152
-737
-15% -$20.8K
ABUS icon
394
Arbutus Biopharma
ABUS
$805M
$116K 0.04%
42,675
+5,227
+14% +$14.2K
DICE
395
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$116K 0.04%
7,482
+1,166
+18% +$18.1K
CRNX icon
396
Crinetics Pharmaceuticals
CRNX
$3.35B
$115K 0.04%
6,180
-166
-3% -$3.09K
RLMD icon
397
Relmada Therapeutics
RLMD
$54.8M
$115K 0.04%
6,068
-2,448
-29% -$46.4K
PGEN icon
398
Precigen
PGEN
$1.3B
$114K 0.04%
85,000
+41,072
+93% +$55.1K
TGTX icon
399
TG Therapeutics
TGTX
$5.11B
$114K 0.04%
26,935
+16,994
+171% +$71.9K
CERE
400
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$113K 0.04%
4,259
-957
-18% -$25.4K
14 15
16
17 18